VBIV
VBI Vaccines Inc
NASDAQ: VBIV · HEALTHCARE · BIOTECHNOLOGY
$0.07
+0.00% today
Updated 2026-04-30
Market cap
$1.87M
P/E ratio
—
P/S ratio
0.20x
EPS (TTM)
$-3.54
Dividend yield
—
52W range
$0 – $0
Volume
—
VBI Vaccines Inc (VBIV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $79.00 | — | — | — | — | — | — | — | $-1.57M | $2.87M | $955000.00 | $548000.00 | $865000.00 | $3.35M | $2.22M | $1.06M | $631000.00 | $1.08M | $8.68M |
| Revenue growth (YoY) | — | — | -100.0% | — | — | — | — | — | — | — | +282.9% | -66.7% | -42.6% | +57.8% | +287.9% | -33.8% | -52.2% | -40.5% | +71.5% | +702.4% |
| Cost of revenue | — | — | $12636.00 | $12636.00 | $8673.00 | — | — | $10.82M | $10.82M | $4.64M | $3.70M | $3.75M | $3.67M | $5.19M | $4.51M | $7.90M | $9.17M | $10.77M | $11.28M | $14.50M |
| Gross profit | — | $79.00 | $-12636.00 | $-12636.00 | $-8673.00 | — | — | $-10.82M | $-10.82M | $-4.64M | $-831000.00 | $-2.80M | $-3.12M | $-4.33M | $-1.15M | $-5.68M | $-8.11M | $-10.14M | $-10.19M | $-5.82M |
| Gross margin | — | 100.0% | — | — | — | — | — | — | — | 295.7% | -29.0% | -293.2% | -569.9% | -500.3% | -34.4% | -255.9% | -764.1% | -1606.8% | -942.1% | -67.0% |
| R&D | — | — | — | — | — | — | — | — | — | $1.44M | $634000.00 | $618000.00 | $9.97M | $20.92M | $38.47M | $26.33M | $14.86M | $19.56M | $15.51M | $9.34M |
| SG&A | $129726.00 | $453907.00 | $453907.00 | $428530.00 | $592925.00 | $731592.00 | $731592.00 | $17.56M | $2.53M | $2.41M | $2.65M | $6.68M | $11.76M | $12.03M | $20.79M | $14.09M | $20.65M | $38.34M | $56.12M | $42.14M |
| Operating income | $-135264.00 | $-137070.00 | $-350182.00 | $-368254.00 | $-576046.00 | $-731592.00 | $-731592.00 | $-17.56M | $-13.77M | $-7.12M | $-4.61M | $-8.84M | $-24.85M | $-37.28M | $-60.41M | $-52.40M | $-43.62M | $-68.03M | $-81.82M | $-55.31M |
| Operating margin | — | -173506.3% | — | — | — | — | — | — | — | 454.0% | -160.7% | -925.2% | -4534.7% | -4309.8% | -1800.5% | -2359.3% | -4110.9% | -10781.6% | -7561.9% | -637.1% |
| EBITDA | $-121090.00 | $-126027.00 | $-424711.00 | $-365341.00 | $-581544.00 | $-744488.00 | $-744488.00 | $-16.22M | $-13.44M | $-7.61M | $-66.41M | $-9.80M | $-24.24M | $-36.55M | $-59.24M | $-46.11M | $-41.97M | $-66.20M | $-79.76M | $-53.32M |
| EBITDA margin | — | -159527.8% | — | — | — | — | — | — | — | 485.0% | -2315.4% | -1026.2% | -4424.1% | -4225.4% | -1765.8% | -2076.0% | -3955.2% | -10490.8% | -7371.4% | -614.2% |
| EBIT | $-124187.00 | $-127143.00 | $-425386.00 | $-366039.00 | $-582448.00 | $-745460.00 | $-745460.00 | $-16.22M | $-13.46M | $-7.64M | $-66.43M | $-10.94M | $-24.27M | $-36.60M | $-59.41M | $-46.28M | $-43.62M | $-68.03M | $-81.82M | $-55.31M |
| Interest expense | $11077.00 | $0.00 | $1332.00 | $1332.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.13M | $324000.00 | $2.88M | $3.25M | $2.20M | $2.71M | $4.73M | $4.01M | $8.06M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-51380.00 | $-137070.00 | $-343483.00 | $-205286.00 | $-558396.00 | $-716982.00 | $-716982.00 | $-18.85M | $-13.15M | $-6.65M | $-65.92M | $-14.76M | $-23.20M | $-38.99M | $-63.60M | $-55.80M | $-47.29M | $-72.65M | $-140.95M | $-92.84M |
| Net income growth (YoY) | — | -166.8% | -150.6% | +40.2% | -172.0% | -28.4% | +0.0% | -2529.5% | +30.2% | +49.4% | -890.8% | +77.6% | -57.3% | -68.0% | -63.1% | +12.3% | +15.3% | -53.6% | -94.0% | +34.1% |
| Profit margin | — | -173506.3% | — | — | — | — | — | — | — | 424.3% | -2298.6% | -1545.0% | -4234.5% | -4508.1% | -1895.7% | -2512.6% | -4456.7% | -11513.5% | -13026.9% | -1069.3% |